With the path to blockbusterland now in sight, Travere Therapeutics is ready to hit the ground running after Monday’s ...

Even as Eli Lilly gets underway with its next major obesity launch in Foundayo, an FDA document related to the oral treatment ...

As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the ...

As artificial intelligence continues to rewrite the rules in countless industries, pharma companies are increasingly getting ...

The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing to adequately ...

Monday’s FDA approval makes Filspari the first therapy specifically indicated for FSGS, a condition that represents a $1 ...

Despite encountering a legal roadblock last month in his effort to rework the U.S. vaccine infrastructure, HHS secretary ...

As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for ...

Novartis is making further workforce reductions at its U.S. headquarters in New Jersey, planning to eliminate 114 positions ...

Charles River Laboratories has backed an American Heart Association (AHA) campaign, joining forces with the nonprofit on ...

Envision Pharma Group has hired clinical research veteran Nick Jones as president of its Envision Medical Communications (EMC ...

Fierce Biotech has released its annual ranking of the top 10 pharma R&D budgets of 2025—offering a clear look at which ...